Castel, M A <br/><br/>
Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.  [electronic resource] 

 -  Transplantation proceedings   
 - 2244-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2011.06.054  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Chi-Square Distribution<br/>Cyclosporine--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Graft Rejection--immunology<br/>Graft Survival--drug effects<br/>Heart Transplantation--adverse effects<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Registries<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Spain<br/>Survival Rate<br/>Tacrolimus--therapeutic use<br/>Time Factors<br/>Treatment Outcome